“South Africa’s Parliamentary Portfolio Committee on Health adopted its Budgetary Review and Recommendations Report, with amendments, on 14 October 2026, highlighting concerns about medicine stock-outs and the lack of dedicated budget support for traditional medicine and traditional health practitioners. The concerns raise important questions about medicine availability, healthcare funding, accountability and how the country can build a more inclusive health system.”
South Africa’s Healthcare Policy Faces a Critical Test as Parliament Highlights Medicine Shortages and Funding Gaps
A renewed focus on access to essential healthcare
South Africa’s healthcare system is facing renewed scrutiny following concerns raised by Parliament’s Portfolio Committee on Health about medicine shortages and insufficient financial support for traditional medicine. The committee adopted its Budgetary Review and Recommendations Report, with amendments, on 14 October 2026, drawing attention to issues that affect healthcare access, public expenditure and the country’s broader health-policy objectives.
The development is significant because healthcare policy is not determined by legislation alone. Its success depends on whether public institutions have sufficient resources, essential medicines reach patients, healthcare workers can provide appropriate treatment and public funds are managed effectively.
For millions of South Africans who depend on public clinics and hospitals, medicine availability can determine whether chronic illnesses remain controlled, infections receive timely treatment and potentially serious complications are prevented. Consequently, medicine stock-outs are not merely administrative inconveniences. They can become barriers to equitable healthcare and undermine public confidence in the health system.
The committee’s concerns also highlight the need to consider traditional healthcare practices within national planning. Many South Africans consult traditional health practitioners alongside conventional medical professionals, making cooperation, appropriate safeguards and evidence-informed policy important considerations for the future of healthcare delivery.
Medicine shortages threaten continuity of care
Access to essential medicines remains a central responsibility of any effective public healthcare system. Patients need reliable supplies of prescribed treatments, particularly when managing long-term conditions that require regular medication.
According to Parliament’s statement, committee members raised serious concerns about medicine stock-outs at healthcare facilities across the country, including reports involving chronic and life-saving treatments.
When a medicine is unavailable, patients may have to visit another facility, return on a later date or seek alternatives. Each option can create additional costs, especially for people who must pay for transport, miss work or arrange childcare to attend appointments.
For patients with limited financial resources, repeated visits can become an obstacle to treatment. Some may postpone collecting medication or interrupt their prescribed treatment while waiting for supplies to return.
The consequences depend on the medicine, the patient’s condition and the duration of the shortage. Nevertheless, disruptions can create avoidable risks, making reliable procurement and distribution an important public-health priority.
Medicine availability also depends on several connected processes. Health authorities must estimate demand accurately, allocate budgets, procure appropriate products, manage suppliers, maintain storage facilities and distribute stock to individual clinics and hospitals.
A weakness at any stage can affect patients. For example, inadequate forecasting may leave a facility without sufficient stock, while delayed procurement or distribution can prevent available medicines from reaching the places where they are needed.
Addressing shortages therefore requires more than emergency purchases. It calls for consistent monitoring, transparent reporting and clear responsibility for resolving supply problems.
Accountability and better planning are essential
The parliamentary concerns create an opportunity for health authorities to examine whether existing systems identify shortages early enough and respond effectively.
Facilities need reliable information about medicines in stock, expected deliveries, patient demand and alternative treatment options. District and provincial managers also need information that allows them to identify recurring problems and intervene before patients are affected.
A stronger monitoring system could help officials distinguish between isolated delivery delays and persistent procurement or distribution failures. Publishing appropriate shortage information could also help healthcare workers plan treatment and allow the public to understand what action is being taken.
However, reporting must be accompanied by corrective measures. A dashboard identifying unavailable medicines will have limited value if procurement disputes remain unresolved or facilities cannot obtain replacements.
Accountability should therefore include investigating recurring shortages, documenting decisions, setting clear responsibilities and communicating realistic timelines for restoring supplies.
Healthcare workers also need practical support when medicines are unavailable. They should receive appropriate clinical guidance about alternatives and referral arrangements rather than being left to manage shortages without sufficient information.
Importantly, individual facilities cannot resolve every supply-chain problem independently. National procurement arrangements, provincial budgets, supplier performance and local inventory management can all influence availability. Effective policy must recognise these relationships while ensuring that responsibility does not become so dispersed that no institution is answerable for failures.
Traditional medicine requires a clearer place in health planning
The committee also expressed concern about the exclusion of traditional medicine from departmental budgeting and planning processes. Members highlighted the absence of a dedicated allocation for traditional medicine and traditional health practitioners, despite the reliance of many South Africans on traditional healthcare practices.
This issue raises broader questions about inclusion, regulation and the relationship between different healthcare traditions.
Traditional health practitioners play important roles in some communities, where cultural familiarity, local knowledge and accessibility influence decisions about seeking care. Policymakers must understand these realities when designing services intended to reach diverse populations.
Nevertheless, recognising traditional healthcare does not mean every treatment should automatically be considered safe or effective. Appropriate standards, patient protections and evidence-informed evaluation remain essential.
A coherent policy framework could clarify professional responsibilities, support suitable training, establish referral arrangements and identify areas where collaboration may benefit patients.
For instance, patients experiencing symptoms that require urgent clinical assessment should be encouraged to obtain appropriate medical attention. Where traditional practitioners and conventional healthcare providers interact, clear communication can help reduce delays and misunderstandings.
Budget planning is important because policy commitments require resources to become operational. Without defined responsibilities and appropriate funding, initiatives intended to improve coordination may remain largely aspirational.
Dedicated funding would not, by itself, guarantee better outcomes. Authorities would still need to establish priorities, define eligible activities, monitor expenditure and assess whether funded programmes provide meaningful benefits.
Balancing inclusion with patient safety
Integrating different healthcare practices presents both opportunities and challenges. Policymakers must respect cultural traditions while ensuring that patients receive safe, appropriate and timely care.
Clear referral pathways could help patients move between services when necessary. Information-sharing arrangements, where appropriate and consistent with privacy protections, could also help healthcare professionals understand relevant aspects of a patient’s treatment.
Training and public education would be equally important. Patients should have access to understandable information about treatment options, potential risks and circumstances requiring urgent medical attention.
Traditional practitioners should not be expected to replace hospitals, doctors or nurses in situations requiring specialised clinical treatment. Similarly, conventional healthcare institutions should understand the communities they serve and avoid dismissing patients’ cultural experiences.
The policy objective should be to improve patient outcomes rather than create competition between healthcare systems.
Consultation with communities, professional organisations, researchers and healthcare authorities could help establish workable standards. Any future programme should also include measurable indicators, enabling government to assess whether cooperation improves access, safety and patient experience.
Healthcare funding and the pressure on public services
The concerns about medicines and traditional healthcare funding emerge within a broader debate about how South Africa allocates limited public resources.
Healthcare departments must balance expenditure on personnel, facilities, equipment, medicines, emergency services, prevention and long-term programmes. Funding decisions can therefore have consequences across multiple areas of service delivery.
When essential medicines are unavailable, patients may require additional consultations or more complex treatment. Preventable complications can increase pressure on already stretched facilities. Reliable supplies are therefore important not only for individual health but also for responsible public expenditure.
South Africa has also taken steps to address medicine-sector pressures. A government announcement published on 30 September 2026 confirmed a 2.88% adjustment to the regulated Single Exit Price of medicines in the private sector, effective from 1 October. The government said the adjustment was intended to help manufacturers manage exceptional cost pressures while balancing affordability and supply sustainability.
That measure concerns private-sector medicine pricing and should not be confused with a direct solution to shortages in state facilities. Nevertheless, it illustrates the wider policy challenge of maintaining medicine supplies while protecting affordability.
For public healthcare, procurement decisions must consider price, product quality, supplier reliability and the ability to deliver medicines when required.
The government has also faced debate about support for domestic pharmaceutical manufacturing. Business Day reported on 13 October that President Cyril Ramaphosa had directed the establishment of a government-business task force to address challenges affecting the pharmaceutical sector, including concerns about procurement policies and locally produced medicines.
Domestic production may offer supply-chain advantages in some circumstances, but its contribution depends on manufacturing capacity, competitive pricing, quality standards and dependable delivery. Policymakers must evaluate these factors rather than assume that domestic or imported medicines are invariably the better option.
What the parliamentary report means for patients
For patients, the practical test of healthcare policy is whether services become more reliable, accessible and responsive.
People receiving treatment for chronic conditions need predictable access to prescriptions. Families seeking urgent care need confidence that facilities can provide appropriate treatment or arrange referrals. Communities using traditional healthcare need clear information about safe practice and access to conventional services when required.
The parliamentary report does not, by itself, establish that shortages have been resolved or that new funding has been approved. Instead, it identifies concerns requiring attention through oversight, planning and government action.
The next steps will matter. Authorities can demonstrate progress by publishing credible information about medicine availability, explaining how recurrent shortages are being addressed and reporting on the implementation of relevant recommendations.
For traditional healthcare, progress would require clearer planning, appropriate consultation and transparent decisions about funding, regulation and evaluation.
Civil society organisations, patient groups and professional bodies can contribute by documenting service barriers and identifying practical improvements. Their evidence can help policymakers understand how decisions made at national level affect patients at local facilities.
The road ahead for healthcare reform
South Africa’s healthcare-policy challenge is to translate oversight into improvements that patients can experience.
Reliable medicine supplies require sound forecasting, effective procurement, efficient distribution and accountability throughout the supply chain. Inclusive healthcare planning requires meaningful consultation, appropriate safeguards and transparent decisions about the allocation of public resources.
These priorities are connected by a common principle: healthcare policy should be judged by its ability to protect patients and improve access to appropriate treatment.
The parliamentary committee’s concerns provide an important reminder that ambitious healthcare objectives cannot succeed without dependable everyday services. A policy framework may establish broad national goals, but patients experience the system through the medicines available at their clinic, the care provided by health professionals and the ability to obtain help when they need it.
The adoption of the committee’s report is therefore an opportunity for government departments to demonstrate how identified weaknesses will be addressed. Clear implementation plans, measurable targets and regular public reporting would help establish whether recommendations lead to meaningful change.
Ultimately, a stronger healthcare system must combine affordability, availability, safety and accountability. It must also recognise the different ways people seek care while ensuring that appropriate clinical treatment remains accessible.
As South Africa continues debating healthcare reform, the central question is not simply how policies are written or budgets are allocated. It is whether those decisions result in better services, fewer preventable disruptions and greater confidence among the people who depend on the health system.
The parliamentary report places these questions firmly on the agenda. The responsibility now lies with relevant authorities to turn the concerns into practical improvements, communicate progress honestly and ensure that patients remain at the centre of healthcare decision-making.
